Literature DB >> 8800749

Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II).

C B Whitley1, R S McIvor, E L Aronovich, S A Berry, B R Blazar, S R Burger, J H Kersey, R A King, A J Faras, R E Latchaw, J McCullough, D Pan, N K Ramsay, D F Stroncek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8800749     DOI： 10.1089/hum.1996.7.4-537

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  7 in total

Review 1.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

2.  High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.

Authors:  K E Pollok; H Hanenberg; T W Noblitt; W L Schroeder; I Kato; D Emanuel; D A Williams
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 3.  Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.

Authors:  Dao Pan
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

Review 4.  Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Authors:  T M Clay; M C Custer; P J Spiess; M I Nishimura
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 5.  Gene therapy for neurologic manifestations of mucopolysaccharidoses.

Authors:  Daniel A Wolf; Sharbani Banerjee; Perry B Hackett; Chester B Whitley; R Scott McIvor; Walter C Low
Journal:  Expert Opin Drug Deliv       Date:  2014-12-16       Impact factor: 6.648

Review 6.  Update on treatment of lysosomal storage diseases.

Authors:  S Bruni; L Loschi; C Incerti; O Gabrielli; G V Coppa
Journal:  Acta Myol       Date:  2007-07

7.  Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases.

Authors:  Edina Poletto; Gabriela Pasqualim; Roberto Giugliani; Ursula Matte; Guilherme Baldo
Journal:  Genet Mol Biol       Date:  2019-05-23       Impact factor: 1.771
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.